Portfolio of central nervous system products. The portfolio comprises rights to the non-core pharmaceutical products and drugs which addresses psychiatric and neurological disorders.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore H. Lundbeck (US non-core product portfolio)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore H. Lundbeck (US non-core product portfolio)‘s full profile, request access.
Request a free trial